NIH $ frozen amid conflict probe

| 2 min read

An Emory University psychiatrist under investigation by a Senate committee for allegedly failing to disclose more than a million dollars in pharmaceutical company pay has stepped down as principal investigator on a $9.3 million National Institutes of Health research grant. The researcher, Charles Nemeroff, is the linkurl:second;http://www.the-scientist.com/blog/display/54935/ scientist who has recently stepped down from an NIH grant amid Senate scrutiny of undisclosed conflicts of interest. According to Ron Sauder, an Emory spokesperson interviewed by the linkurl:__Atlanta Journal-Constitution__,;http://www.ajc.com/metro/content/metro/dekalb/stories/2008/10/14/nemeroff_emory_funds.html the NIH will withhold the remainder of funding on the five-year grant - which began in July 2006 - "pending resolution of outstanding issues relating to conflict of interest procedures." Nemeroff linkurl:resigned;http://www.the-scientist.com/blog/display/55072/ his chairmanship of Emory's psychiatry department on October 3 as the university launched its own investigation into his apparent failure to disclose industry ties. The NIH is now requiring the university's Office of Sponsored Programs (OSP) and all Emory researchers hoping to secure agency funding to submit and assure detailed records of who is participating on proposed projects and what financial conflicts they may have. "As you may know, the University has been under scrutiny in connection with our business practices for the management of research financial conflict of interest," Emory's vice president for research administration David Wynes wrote in a linkurl:memo;http://www.pharmalot.com/wp-content/uploads/2008/10/emory-coi-1a.jpg to university researchers last week. "It is important to note that, in the future, OSP will non [sic] submit any NIH grant application until disclosures have been received for every Investigator participating in the study." In the memo, Wynes explained that "as of October 8, 2008 the NIH has imposed special award conditions on all awards made to Emory University. The special award conditions will affect both the submission of proposals to the NIH as well as the receipt of funding." (Thanks to the linkurl:__Pharmalot__;http://www.pharmalot.com/2008/10/nih-requires-emory-to-disclose-all-conflicts/ blog for posting a copy of the memo.) Nemeroff was originally accused of linkurl:failing to report payments from drug maker GlaxoSmithKline;http://www.the-scientist.com/blog/display/55072/ by Senate Finance Committee ranking Republican Charles Grassley, who has recently linkurl:investigated;http://www.the-scientist.com/blog/display/55058/ similar apparent indiscretions among other NIH-funded researchers.

NIH $ frozen amid conflict probe

The Scientist ARCHIVES

Become a Member of

Meet the Author

Bob Grant

Related Research Resources

Bunsen Burners and Bad Hair Days

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Taking the Guesswork Out of Quality Control Standards

PFAS: The Forever Chemicals

Unlocking the Unattainable in Gene Construction

Comparing Analytical Solutions for High-Throughput Drug Discovery

Products

Product News

Thermo Scientific™ Centrifuges with GreenCool Technology

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Launches Research Grant to Empower Mapping the RNome

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer